Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
HSGX

Histogenics

$0.75

-0.008 (-1.06%)

, CVX

Chevron

$118.40

-0.52 (-0.44%)

10:03
09/06/18
09/06
10:03
09/06/18
10:03
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…

HSGX

Histogenics

$0.75

-0.008 (-1.06%)

CVX

Chevron

$118.40

-0.52 (-0.44%)

COP

ConocoPhillips

$72.13

-0.88 (-1.21%)

BEN

Franklin Resources

$30.51

-0.91 (-2.90%)

HQY

HealthEquity

$94.82

-2.18 (-2.25%)

RIO

Rio Tinto

$47.09

0.32 (0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 10

    Sep

HSGX

Histogenics

$0.76

-1.982 (-72.34%)

09:02
09/06/18
09/06
09:02
09/06/18
09:02
Recommendations
Histogenics analyst commentary at Needham »

Histogenics price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

HSGX

Histogenics

$0.76

-1.982 (-72.34%)

16:39
09/05/18
09/05
16:39
09/05/18
16:39
Downgrade
Histogenics rating change at BTIG »

BTIG downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 05

    Sep

HSGX

Histogenics

$0.76

-1.982 (-72.34%)

16:28
09/05/18
09/05
16:28
09/05/18
16:28
Downgrade
Histogenics rating change at BTIG »

Histogenics downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 05

    Sep

VCEL

Vericel

$13.65

1.975 (16.92%)

, HSGX

Histogenics

$0.82

-1.92 (-70.07%)

14:08
09/05/18
09/05
14:08
09/05/18
14:08
Recommendations
Vericel, Histogenics analyst commentary at Piper Jaffray »

Piper sees less…

VCEL

Vericel

$13.65

1.975 (16.92%)

HSGX

Histogenics

$0.82

-1.92 (-70.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 05

    Sep

HSGX

Histogenics

$0.90

-1.84 (-67.15%)

12:38
09/05/18
09/05
12:38
09/05/18
12:38
Recommendations
Histogenics analyst commentary at H.C. Wainwright »

Histogenics still has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 05

    Sep

HSGX

Histogenics

$2.74

-0.17 (-5.84%)

06:05
09/05/18
09/05
06:05
09/05/18
06:05
Hot Stocks
Histogenics' NoeCart did not meet primary endpoint of Phase 3 trial »

Histogenics' Phase 3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 05

    Sep

Over a month ago
HSGX

Histogenics

$2.65

-0.05 (-1.85%)

17:06
08/17/18
08/17
17:06
08/17/18
17:06
Syndicate
Breaking Syndicate news story on Histogenics »

Histogenics files $75M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSGX

Histogenics

$2.32

0.01 (0.43%)

06:38
08/09/18
08/09
06:38
08/09/18
06:38
Earnings
Breaking Earnings news story on Histogenics »

Histogenics reports Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

HSGX

Histogenics

$2.25

0.08 (3.69%)

08:04
07/31/18
07/31
08:04
07/31/18
08:04
Hot Stocks
Histogenics appoints E. Lynne Kelley as CMO »

Histogenics Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.